Venetoclax Plus Bendamustine-Rituximab or Bendamustine-Obinutuzumab in Chronic Lymphocytic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Haematologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)
Haematologica 2021 Nov 01;106(11)2834-2844, S Stilgenbauer, F Morschhauser, CM Wendtner, G Cartron, M Hallek, B Eichhorst, MF Kozloff, T Giever, G Lozanski, Y Jiang, H Huang, DS Pignataro, W Schary, K Humphrey, M Mobasher, G SallesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.